Skip to the page

Data / Drug companies / Non-Standardized House Dust Allergenic Extract

Non-Standardized House Dust Allergenic Extract drugs: 1 drug from 8 companies in the FDA NDC directory

Non-Standardized House Dust Allergenic Extract is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 19 products in this class from 8 companies, covering 1 drug by generic name. The main marketing category is unapproved homeopathic products, and the newest product started marketing on October 2, 2025.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

  • 8Companies
  • 19Products
  • 1Drugs by generic name

Drugs in the Non-Standardized House Dust Allergenic Extract class

Ranked by number of companies that list the drug.

DrugProducts hereCompanies listing it
House dust22

Companies with the most products in this class

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Newton Laboratories, Inc.8liquid; pelletUnapproved homeopathic productsSeptember 25, 2023
Nutritional Specialties, Inc.3sprayUnapproved homeopathic productsOctober 2, 2025
Apex Energetics Inc.2solution/ dropsUnapproved homeopathic productsMarch 15, 1993
Professional Complementary Health Formulas2liquidUnapproved homeopathic productsAugust 15, 1984
Allermed Laboratories, Inc.1injectionBiologics (BLA)March 12, 1974
BioActive Nutritional, Inc.1liquidUnapproved homeopathic productsJune 21, 2022
Dna Labs, Inc.1solutionUnapproved homeopathic productsJanuary 1, 1990
Energique, Inc.1liquidUnapproved homeopathic productsMarch 24, 2020

Dosage forms

Dosage formProductsShare
Liquid947.4%
Spray315.8%
Pellet315.8%
Solution/ drops210.5%
Injection15.3%
Solution15.3%

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.